KRT19 and breast carcinoma: It works by the detection of raised copy number of the cytokeratin 19 gene (CK19) as a surrogate marker of the presence of breast cancer within sentinel lymph nodes62, and is used as a proxy marker for axillary lymph node positivity in breast cancer.